Designing a new drug against pancreatic cancer
Stopping the growth and spread of pancreatic cancer is the focus of a new project led by researchers at the University of Hertfordshire and funded by the Association for International Cancer Research.Pancreatic cancer is the tenth most common cancer in the UK, around 8,500 people were diagnosed in 2010. It is an aggressive cancer that very few people survive from – only around four per cent of pancreatic cancer patients survive for five years or more, making it one of the lowest survival rates. It is often diagnosed at an advanced stage when the cancer has become very aggressive and it